What are the indications, dosing regimen, contraindications, precautions, and adverse effects of Rofinac (aceclofenac 100 mg/paracetamol 325 mg)?

Rofinac (Aceclofenac 100 mg/Paracetamol 325 mg)

Rofinac is indicated for acute and chronic musculoskeletal pain conditions including osteoarthritis, low back pain, and inflammatory conditions, dosed as one tablet twice daily for up to 7 days acutely or longer for chronic conditions, but requires careful patient selection due to significant cardiovascular, gastrointestinal, and renal risks inherent to NSAID therapy.

Indications

Rofinac combines aceclofenac (an NSAID) with paracetamol for synergistic analgesic and anti-inflammatory effects. Based on the evidence:

• Acute pain conditions: Low back pain, viral pharyngitis, episiotomy pain, dental pain 1, 2, 3
• Chronic inflammatory conditions: Osteoarthritis (particularly knee OA), rheumatoid arthritis, ankylosing spondylitis, scapulohumeral periarthritis 4, 5, 6
• Musculoskeletal disorders with both inflammatory and pain components 5

The combination shows superior efficacy to paracetamol alone, with aceclofenac demonstrating faster onset of pain relief (within 24 hours vs 3 days for paracetamol alone) 2.

Dosing Regimen

Standard dosing: One tablet (aceclofenac 100 mg + paracetamol 325 mg) twice daily 7, 1

Duration considerations:

• Acute conditions: 7 days 1
• Chronic conditions: May be continued longer with appropriate monitoring 4

Critical paracetamol safety limits 8:

• Maximum 6 doses in 24 hours
• Never exceed 4000 mg total paracetamol daily from all sources
• With Rofinac twice daily (650 mg paracetamol total), patients have 3350 mg remaining allowance—must account for all other paracetamol-containing products

Absolute Contraindications

Based on FDA labeling and guidelines 9, 10:

• Allergy to aceclofenac, diclofenac, or any NSAID analogue
• Active peptic ulcer disease
• Asthma, acute rhinitis, or urticaria triggered by NSAIDs or aspirin
• Severe liver disease (paracetamol component) 8
• Acetaminophen allergy or prior severe skin reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis) 8

Major Precautions and High-Risk Populations

Cardiovascular Risk 10

Avoid or use extreme caution in:

• History of myocardial infarction or ischemic heart disease
• Congestive heart failure (NSAIDs worsen fluid retention)
• Uncontrolled hypertension (expect 5 mmHg average BP increase)
• Recent cardiac stent placement
• Cerebrovascular disease

All NSAIDs increase cardiovascular morbidity including MI risk. The combination of COX-2 effects with traditional NSAID risks makes cardiovascular assessment mandatory before prescribing.

Renal Complications 10

High-risk patients requiring avoidance or intensive monitoring:

• Pre-existing renal disease (any stage)
• Congestive heart failure
• Cirrhosis
• Concurrent ACE inhibitors or angiotensin receptor blockers (ARBs)
• Beta-blocker therapy

Monitoring protocol for high-risk patients: Obtain baseline serum creatinine, then monitor weekly for 3 weeks after initiation 10. Approximately 2% of NSAID users develop renal complications requiring discontinuation.

Gastrointestinal Risk 10

Annual serious GI bleeding risk 10:

• Age <45: 1 in 2,100
• Age >75: 1 in 110
• With anticoagulants: 5-6 times baseline risk
• History of ulcers: 5% recurrence risk in 6 months even with gastroprotection

Risk mitigation: Consider adding proton pump inhibitor (PPI) for patients with prior ulcer history, age >65, or concurrent anticoagulation 10.

Hepatotoxicity 10, 8

• Aceclofenac (like diclofenac) shows higher hepatotoxicity rates than other NSAIDs
• Paracetamol component adds cumulative liver risk
• Avoid in patients with impaired hepatic function
• Risk of idiosyncratic liver toxicity with both components
• Alcohol use (≥3 drinks daily) dramatically increases hepatotoxicity risk 8

Hematologic Considerations 10

Perioperative management:

• Stop NSAIDs for 5 elimination half-lives before surgery
• For aceclofenac: discontinue 2-3 days preoperatively
• Avoid in patients with platelet defects or thrombocytopenia
• Increased hemorrhagic stroke risk (though small)

Drug Interactions 10

Increased risk combinations:

• Warfarin (requires consultation before use) 8
• Other NSAIDs or aspirin (avoid concurrent use)
• Anticoagulants (5-6 fold increased bleeding risk)
• ACE inhibitors/ARBs (increased renal failure risk)
• Beta-blockers (increased renal complications)

Adverse Effects

Common (10-20% incidence) 10, 9

• Dyspepsia and abdominal pain
• Nausea
• GI discomfort
• Headache
• Dizziness and drowsiness

Serious but Less Common 9

• Rash, urticaria, skin reactions
• Enuresis symptoms
• GI bleeding (age-dependent risk as above)
• Acute renal failure
• Hepatotoxicity
• Cardiovascular events

Life-Threatening 8

• Severe skin reactions (Stevens-Johnson syndrome)
• Acute liver failure from paracetamol overdose
• GI perforation or bleeding
• Myocardial infarction

Paracetamol overdose warning 8: Liver damage may occur without immediate symptoms. Any suspected overdose requires immediate medical attention and poison control contact (1-800-222-1222), even without symptoms.

Clinical Efficacy Evidence

Aceclofenac demonstrates superior or equivalent efficacy compared to paracetamol alone 4, 2, 3 and comparable efficacy to other NSAIDs 6. The combination with paracetamol provides additive analgesia 1. Meta-analysis shows aceclofenac improves physical function and has fewer GI adverse events than other NSAIDs 6, though this advantage may be modest.

Key Clinical Pitfalls

1. Paracetamol stacking: Patients often don't recognize paracetamol in combination products—explicitly warn about total daily limits
2. Cardiovascular screening neglect: Must assess CV risk before any NSAID prescription
3. Renal monitoring omission: High-risk patients need baseline and follow-up creatinine
4. Alcohol interaction: Three or more drinks daily dramatically increases hepatotoxicity risk
5. Chronic use without gastroprotection: Consider PPI co-prescription for elderly or high-risk patients
6. Perioperative continuation: Must discontinue 2-3 days before surgery